Well $1.5M has always been a pretty good figure to work with for the company - standard cash burn has been pretty much $1.5M a quarter balanced some a little more some a little less but always back to around that figure. They also don't usually look at moving for cash until the dip below that $1.5M figure so out on a limb probably some time in 2nd quarter next year.
We all know guidance had been pretty touch go here but assuming things fall in line they should (hopefully) be hitting inflection points well prior to that, Ideally in coming weeks.
> Genentech to deliver on MAJOR milestone sometime in the next few weeks EY2014
hopefully leading to expanded relationship into 2015.
> Key data on Oncology program Q1 2015
> Considerable interest from various parties on EET, Oncology & Platform -- so any time ??
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)